Roopal Thakkar - SVP, CMO, GLOBAL THERAPEUTICS at AbbVie Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Cmo, Global Therapeutics
Stock Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Roopal Thakkar since 6/2/2023

Holdings reported by Roopal Thakkar for AbbVie Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock, $0.01 par value 23,259 $4.16M $178.99 Feb 28, 2024 Direct
Option (Right to buy) 13,868 $2M $144.54 Feb 15, 2024 Direct Common Stock

Transactions reported by Roopal Thakkar for AbbVie Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership